listen to the webcast. SI discusses this briefly and it was doing something, from what I heard. patient profile got older and use of RemL was very late stage in the available treatments. worth a listen.
Novartis deal on the rocks, page-87
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.008(0.64%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.686M | 1.439M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 41479 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 32235 | 7 |
View Market Depth
| Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |